Registered Malawi · PMRA

MOXOZOL 240MG SUSPENSION

PAEDIATRIC CO-TRIMOXAZOLE

PMPB/PL388/61 SUSPENSION

What it does

This medication is suitable for children and is used to treat various conditions.

Commonly used for: fever, pain relief, infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL388/61
Registration date
25/06/2014
Expiry date
31/03/2024
Status
Registered
Active ingredient
PAEDIATRIC CO-TRIMOXAZOLE
Dosage form
SUSPENSION
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:42 · updated 2026-09-19 04:30:23

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

This medication is suitable for children and is used to treat various conditions.

What it treats

  • fever
  • pain relief
  • infections

How it works

It helps to reduce fever and relieve pain by acting on the brain.

Who it's for

This medicine is intended for children who need treatment for common illnesses.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: paediatric

Paediatric medications are specifically formulated for children, taking into account their unique physiological characteristics and developmental stages. Dosing in paediatrics often differs significantly from adults due to variations in body weight, organ maturity, and metabolism. It is critical to use age-appropriate formulations to ensure safety and efficacy in this population.

Indications

  • Various paediatric conditions including infections, asthma, attention-deficit hyperactivity disorder (ADHD), diabetes, and congenital disorders.
  • Management of pain and fever in children.
  • Treatment of chronic conditions such as epilepsy and cystic fibrosis.

Dosage

Children: Refer to BNF for Children for paediatric dosing guidelines.

Adults: Refer to specific BNF guidelines for adult dosing.

Mechanism of action

The mechanism of action for paediatric medications varies widely depending on the specific drug. Generally, paediatric formulations aim to provide precise therapeutic effects while minimizing adverse effects, tailored to the pharmacokinetic and pharmacodynamic profiles of children.

Pharmacodynamics

Pharmacodynamics in paediatrics can differ from adults due to developmental differences in organ systems, receptor sensitivity, and drug metabolism. Children may exhibit heightened sensitivity to certain medications, which necessitates careful monitoring and adjustment of dosages compared to adult populations.

Pharmacokinetics

Pharmacokinetics in children is influenced by factors such as age, weight, and organ maturity. Absorption can vary with age, distribution may differ due to body composition, metabolism is often higher in younger children, and renal function matures over time, affecting excretion. These factors necessitate careful consideration of dosing regimens and frequency.

Pregnancy

The effects of pediatric formulations during pregnancy are not well-established. Consult healthcare professionals for specific guidance.

Breast-feeding

The safety of pediatric medications during breastfeeding varies by drug. Consult healthcare professionals for specific guidance.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.